ERBB2 and breast cancer: Univariate analysis results showed that age, stage 3, triple-negative subtype, and SRD5A3 were significantly related to OS in BC patients (all P < 0.05), while gender, stage 4, and HER2+ subtype had no remarkable relationship with OS in BC.